[1]Yu CC,Chang CY,Liu CE,et al. Drug resistance pattern of Mycobacterium tuberculosis complex at a medical center in central Taiwan, 2003-2007.J Microbiol Immunol Infect,2010,43(4):285-290.[2]Gavín P, Iglesias MJ, Jiménez MS, et al. Multidrug-resistant Mycobacterium tuberculosis strain from Equatorial Guinea detected in Spain.Emerg Infect Dis, 2009,15(11):1858-1860.[3]Gumbo T. New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.Antimicrob Agents Chemother, 2010, 54(4):1484-1491.[4]叶应妩,王毓三,申子瑜. 全国临床检验操作规程. 3 版. 南京: 东南大学出版社,2006.[5]中华医学会.临床诊疗指南结核病分册.北京:人民卫生出版社,2006.[6]Kim BJ, Lee KH, Yun YJ, et al. Simultaneous identification of rifampin-resistant Mycobacterium tuberculosis and nontuberculous mycobacteria by polymerase chain reaction-single strand conformation polymorphism and sequence analysis of the RNA polymerase gene (rpoB). J Microbiol Methods, 2004, 58 (1):111-118.[7]Cade CE, Dlouhy AC, Medzihradszky KF, et al. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation acti-vities. Protein Sci,2010,19(3):458-474.[8]Luckner SR, Liu N, am Ende CW, et al. A slow, tight bin-ding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis. J Biol Chem, 2010, 285(19):14330-14337.[9]Dessen A, Quémard A, Blanchard JS, et al. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science,1995,267(5204):1638-1641.[10]Drobniewski FA, Watterson SA, Wilson SM, et al. A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. J Med Microbiol, 2000,49(3):271-278.[11]Chaoui I, Sabouni R, Kourout M, et al. Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. J Infect Dev Ctries,2009,3(4):278-284.[12]Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.Science, 1994, 263 (5144):227-230.[13]Lee AS, Lim IH,Tang LL, et al. High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore. J Clin Microbiol,2005,43(4):2026-2027.[14]黄海荣,马玙,陈曦,等.中国耐利福平结核分枝杆菌rpoB基因突变特点.中华结核和呼吸杂志,2001,24(4):231-235.[15]Sajduda A, Brzostek A, Poplawska M, et al. Molecular cha-racterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J Clin Microbiol, 2004, 42(6): 2425-2431.[16]周杨,欧喜超,乐军,等. 基因芯片诊断耐多药结核病的临床多中心研究.中华检验医学杂志,2011, 34 (9):793-799. |